PubMed

Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH.

Diabetes Care. 2006 Feb;29(2):334-9.PMID: 16443883 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P.

Diabetes Care. 2008 Apr;31(4):747-52. Epub 2007 Dec 27.PMID: 18162497 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated placental growth factor (PlGF) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Tarnow L, Astrup AS, Parving HH.

Scand J Clin Lab Invest Suppl. 2005;240:73-9.PMID: 16112962 [PubMed - indexed for MEDLINE]Related articles

Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy.

Tarnow L, Hildebrandt P, Hansen BV, Borch-Johnsen K, Parving HH.

Diabetologia. 2005 Jan;48(1):149-55. Epub 2004 Dec 23.PMID: 15616804 [PubMed - indexed for MEDLINE]Related articles

Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.

Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P.

Diabetes Care. 2008 Jun;31(6):1170-6. Epub 2008 Mar 10.PMID: 18332153 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy.

Nguyen TQ, Tarnow L, Jorsal A, Oliver N, Roestenberg P, Ito Y, Parving HH, Rossing P, van Nieuwenhoven FA, Goldschmeding R.

Diabetes Care. 2008 Jun;31(6):1177-82. Epub 2008 Mar 14.PMID: 18344285 [PubMed - indexed for MEDLINE]Related articlesFree article

The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.

Jorsal A, Tarnow L, Lajer M, Ek J, Hansen T, Pedersen O, Parving HH.

Mol Genet Metab. 2008 Jul;94(3):347-51. Epub 2008 May 7.PMID: 18467141 [PubMed - indexed for MEDLINE]Related articles

The natural history of recently diagnosed autonomic neuropathy over a period of 2 years.

Karamitsos DT, Didangelos TP, Athyros VG, Kontopoulos AG.

Diabetes Res Clin Pract. 1998 Oct;42(1):55-63.PMID: 9884034 [PubMed - indexed for MEDLINE]Related articles

Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study.

Astrup AS, Tarnow L, Rossing P, Pietraszek L, Riis Hansen P, Parving HH.

Kidney Int. 2005 Sep;68(3):1250-7.PMID: 16105058 [PubMed - indexed for MEDLINE]Related articles

Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up study.

Astrup AS, Tarnow L, Christiansen M, Hansen PR, Parving HH, Rossing P.

Diabet Med. 2007 Dec;24(12):1381-5. Epub 2007 Oct 29.PMID: 17971180 [PubMed - indexed for MEDLINE]Related articles

[Cardiovascular autonomic neuropathy and nephropathy in patients with type-1 diabetes mellitus]

Galicka-Latała D, Fedak D, Kuźniewski M, Kawalec E, Solnica B.

Przegl Lek. 2004;61(3):155-8. Polish. PMID: 15518324 [PubMed - indexed for MEDLINE]Related articles

Reduced gastric emptying and mesenteric blood flow in IDDM with cardiac autonomic neuropathy.

Weck M, Ott P, Matthies K.

Acta Med Austriaca. 1997;24(5):180-4.PMID: 9428944 [PubMed - indexed for MEDLINE]Related articles

A 14-year prospective study of autonomic nerve function in Type 1 diabetic patients: association with nephropathy.

Forsén A, Kangro M, Sterner G, Norrgren K, Thorsson O, Wollmer P, Sundkvist G.

Diabet Med. 2004 Aug;21(8):852-8.PMID: 15270788 [PubMed - indexed for MEDLINE]Related articles

Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children.

Chessa M, Butera G, Lanza GA, Bossone E, Delogu A, De Rosa G, Marietti G, Rosti L, Carminati M.

Herz. 2002 Dec;27(8):785-90.PMID: 12574897 [PubMed - indexed for MEDLINE]Related articles

Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study.

Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH.

J Hypertens. 2007 Dec;25(12):2479-85.PMID: 17984670 [PubMed - indexed for MEDLINE]Related articles

Progression of nephropathy in type 2 diabetic patients.

Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH.

Kidney Int. 2004 Oct;66(4):1596-605.PMID: 15458456 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy.

Tarnow L, Rossing P, Nielsen FS, Fagerudd JA, Poirier O, Parving HH.

Diabetes Care. 2000 Jan;23(1):30-3.PMID: 10857964 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patients.

Joseph G, Tarnow L, Astrup AS, Hansen TK, Parving HH, Flyvbjerg A, Frystyk J.

J Clin Endocrinol Metab. 2008 Apr;93(4):1470-5. Epub 2008 Jan 22.PMID: 18211979 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiac autonomic dysfunction in diabetic children.

Massin MM, Derkenne B, Tallsund M, Rocour-Brumioul D, Ernould C, Lebrethon MC, Bourguignon JP.

Diabetes Care. 1999 Nov;22(11):1845-50.PMID: 10546018 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.

Tarnow L, Gall MA, Hansen BV, Hovind P, Parving HH.

Diabetologia. 2006 Oct;49(10):2256-62. Epub 2006 Aug 26.PMID: 16937127 [PubMed - indexed for MEDLINE]Related articles